Pseudohypoaldosteronism type 2 (PHA2) (Gordon syndrome) is caused by the stimulation or prevention of degradation of the NCC co-transporter in the DCT, the same channel implicated in GS. Here, SLC12A3 is linked to pseudohypoaldosteronism type 2.